Skip to main content
Top
Published in:

Open Access 02-05-2024 | Trastuzumab | Research

Role of Early Left Atrial Functional Decline in Predicting Cardiotoxicity in HER2 Positive Breast Cancer Patients Treated With Trastuzumab

Authors: Corinna Bergamini, Lorenzo Niro, Paolo Springhetti, Luisa Ferri, Laura Trento, Ilaria Minnucci, Caterina Maffeis, Elvin Tafciu, Andrea Rossi, Elena Fiorio, Giovanni Benfari, Flavio Ribichini

Published in: Cardiovascular Toxicology | Issue 6/2024

Login to get access

Abstract

Trastuzumab is widely used in HER2 breast cancer. However, it may cause left ventricular (LV) dysfunction. A decrease in LV global longitudinal strain (GLS) has been previously demonstrated to be a good predictor of subsequent cancer therapy related dysfunction (CTRCD). Left atrial morphological remodeling during Trastuzumab therapy has also been shown. The aim of this study is exploring the relationship between early changes in left atrial function and the development of Trastuzumab-induced cardiotoxicity. Consecutive patients with diagnosis of HER2+non-metastatic breast cancer treated with Trastuzumab were prospectively enrolled. A clinical, conventional, and advanced echocardiographic assessment was performed at baseline and every three months, until a one-year follow-up was reached. One-hundred-sixteen patients completed the 12 months follow-up, 10 (9%) cases of CTRCD were observed, all after the sixth month. GLS and LVEF significantly decreased in the CTRCD group at 6 months of follow-up, with an earlier (3 months) significant worsening in left atrial morpho-functional parameters. Systolic blood pressure, early peak atrial longitudinal strain (PALS), peak atrial contraction (PACS) and left atrial volume (LAVI) changes resulted independent predictors of CTRCD at multivariable logistic regression analysis. Moreover, early changes in PALS and PACS resulted good predictors of CTRCD development (AUC 0.85; p = 0.008, p < 0.001 and 0.77; p = 0.008, respectively). This prospective study emphasizes that the decline in PALS and PACS among trastuzumab-treated patients could possibly increase the accuracy in identifying future CTRCD in non-metastatic HER2 breast cancer cases, adding predictive value to conventional echocardiographic assessment.
Literature
1.
go back to reference Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians., 68(6), 394–424.PubMed Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians., 68(6), 394–424.PubMed
2.
go back to reference Siegel, R. L., Miller, K. D., & Jemal, A. (2016). Cancer statistics. CA: A Cancer Journal for Clinicians, 66(1), 7–30.PubMed Siegel, R. L., Miller, K. D., & Jemal, A. (2016). Cancer statistics. CA: A Cancer Journal for Clinicians, 66(1), 7–30.PubMed
3.
go back to reference Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., & Baselga, J. (2001). Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. New England Journal of Medicine, 344(11), 783–792.CrossRefPubMed Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., & Baselga, J. (2001). Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. New England Journal of Medicine, 344(11), 783–792.CrossRefPubMed
4.
go back to reference Sengupta, P. P., Northfelt, D. W., Gentile, F., Zamorano, J. L., & Khandheria, B. K. (2008). Trastuzumab-induced cardiotoxicity: Heart failure at the crossroads. Mayo Clinic Proceedings, 83(2), 197–203.CrossRefPubMed Sengupta, P. P., Northfelt, D. W., Gentile, F., Zamorano, J. L., & Khandheria, B. K. (2008). Trastuzumab-induced cardiotoxicity: Heart failure at the crossroads. Mayo Clinic Proceedings, 83(2), 197–203.CrossRefPubMed
5.
go back to reference Jafari, F., Safaei, A. M., Hosseini, L., Asadian, S., Kamangar, T. M., Zadehbagheri, F., & Rezaeian, N. (2021). The role of cardiac magnetic resonance imaging in the detection and monitoring of cardiotoxicity in patients with breast cancer after treatment: A comprehensive review. Heart Failure Reviews, 26(3), 679–697.CrossRefPubMed Jafari, F., Safaei, A. M., Hosseini, L., Asadian, S., Kamangar, T. M., Zadehbagheri, F., & Rezaeian, N. (2021). The role of cardiac magnetic resonance imaging in the detection and monitoring of cardiotoxicity in patients with breast cancer after treatment: A comprehensive review. Heart Failure Reviews, 26(3), 679–697.CrossRefPubMed
6.
go back to reference Thavendiranathan, P., Negishi, T., Coté, M. A., Penicka, M., Massey, R., Cho, G. Y., Hristova, K., Vinereanu, D., Popescu, B. A., Izumo, M., & Negishi, K. (2018). Single versus standard multiview assessment of global longitudinal strain for the diagnosis of cardiotoxicity during cancer therapy. JACC: Cardiovascular Imaging. https://doi.org/10.1016/j.jcmg.2018.03.003CrossRefPubMed Thavendiranathan, P., Negishi, T., Coté, M. A., Penicka, M., Massey, R., Cho, G. Y., Hristova, K., Vinereanu, D., Popescu, B. A., Izumo, M., & Negishi, K. (2018). Single versus standard multiview assessment of global longitudinal strain for the diagnosis of cardiotoxicity during cancer therapy. JACC: Cardiovascular Imaging. https://​doi.​org/​10.​1016/​j.​jcmg.​2018.​03.​003CrossRefPubMed
8.
go back to reference Negishi, K., Negishi, T., Haluska, B. A., Hare, J. L., Plana, J. C., & Marwick, T. H. (2014). Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection. European Heart Journal—Cardiovascular Imaging, 15(3), 324–333.CrossRefPubMed Negishi, K., Negishi, T., Haluska, B. A., Hare, J. L., Plana, J. C., & Marwick, T. H. (2014). Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection. European Heart Journal—Cardiovascular Imaging, 15(3), 324–333.CrossRefPubMed
9.
go back to reference Thavendiranathan, P., Negishi, T., Somerset, E., Negishi, K., Penicka, M., Lemieux, J., Aakhus, S., Miyazaki, S., Shirazi, M., Galderisi, M., & Marwick, T. H. (2021). Strain-guided management of potentially cardiotoxic cancer therapy. Journal of the American College of Cardiology, 77(4), 392–401.CrossRefPubMed Thavendiranathan, P., Negishi, T., Somerset, E., Negishi, K., Penicka, M., Lemieux, J., Aakhus, S., Miyazaki, S., Shirazi, M., Galderisi, M., & Marwick, T. H. (2021). Strain-guided management of potentially cardiotoxic cancer therapy. Journal of the American College of Cardiology, 77(4), 392–401.CrossRefPubMed
10.
go back to reference Moslehi, J. J., & Witteles, R. M. (2021). Global longitudinal strain in cardio-oncology. Journal of the American College of Cardiology, 77(4), 402–404.CrossRefPubMedPubMedCentral Moslehi, J. J., & Witteles, R. M. (2021). Global longitudinal strain in cardio-oncology. Journal of the American College of Cardiology, 77(4), 402–404.CrossRefPubMedPubMedCentral
11.
go back to reference Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., & Cutter, D. J. (2023). Erratum: 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): developed by the task force on cardio-oncology of the European Society of Cardiology (ESC). European Heart Journal - Cardiovascular Imaging. https://doi.org/10.1093/ehjci/jead080CrossRefPubMed Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., & Cutter, D. J. (2023). Erratum: 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): developed by the task force on cardio-oncology of the European Society of Cardiology (ESC). European Heart Journal - Cardiovascular Imaging. https://​doi.​org/​10.​1093/​ehjci/​jead080CrossRefPubMed
12.
go back to reference Bergamini, C., Dolci, G., Rossi, A., Torelli, F., Ghiselli, L., Trevisani, L., Vinco, G., Truong, S., La Russa, F., Golia, G., & Molino, A. (2018). Left atrial volume in patients with HER2-positive breast cancer: One step further to predict trastuzumab-related cardiotoxicity. Clinical Cardiology, 41(3), 349–353.CrossRefPubMedPubMedCentral Bergamini, C., Dolci, G., Rossi, A., Torelli, F., Ghiselli, L., Trevisani, L., Vinco, G., Truong, S., La Russa, F., Golia, G., & Molino, A. (2018). Left atrial volume in patients with HER2-positive breast cancer: One step further to predict trastuzumab-related cardiotoxicity. Clinical Cardiology, 41(3), 349–353.CrossRefPubMedPubMedCentral
13.
go back to reference Bergamini, C., Benfari, G., Dolci, G., Torelli, F., Ghiselli, L., Trevisani, L., Truong, S., Vinco, G., La Russa, F., Golia, G., & Molino, A. (2018). Usefulness of left atrial remodeling in predicting cardiactoxicity during trastuzumab therapy for breast cancer. The American Journal of Cardiology, 122(5), 885–889.CrossRefPubMed Bergamini, C., Benfari, G., Dolci, G., Torelli, F., Ghiselli, L., Trevisani, L., Truong, S., Vinco, G., La Russa, F., Golia, G., & Molino, A. (2018). Usefulness of left atrial remodeling in predicting cardiactoxicity during trastuzumab therapy for breast cancer. The American Journal of Cardiology, 122(5), 885–889.CrossRefPubMed
14.
go back to reference Bakirci, E. M., Degirmenci, H., Hamur, H., Cosgun, M. S., Coskun, R., Gunduz, T., Tan, M., Dogan, M. O., Tanriseven, H. I., Cakir, M., & Buyuklu, M. (2021). Predictors of left atrial remodeling in newly diagnosed hypertensive patients: A speckle-tracking echocardiographic study. The International Journal of Cardiovascular Imaging, 37(10), 2881–2889.CrossRefPubMed Bakirci, E. M., Degirmenci, H., Hamur, H., Cosgun, M. S., Coskun, R., Gunduz, T., Tan, M., Dogan, M. O., Tanriseven, H. I., Cakir, M., & Buyuklu, M. (2021). Predictors of left atrial remodeling in newly diagnosed hypertensive patients: A speckle-tracking echocardiographic study. The International Journal of Cardiovascular Imaging, 37(10), 2881–2889.CrossRefPubMed
16.
go back to reference Santos, A. B., Roca, G. Q., Claggett, B., Sweitzer, N. K., Shah, S. J., Anand, I. S., Fang, J. C., Zile, M. R., Pitt, B., Solomon, S. D., & Shah, A. M. (2016). Prognostic relevance of left atrial dysfunction in heart failure with preserved ejection fraction. Circulation: Heart Failure, 9(4), e002763.PubMed Santos, A. B., Roca, G. Q., Claggett, B., Sweitzer, N. K., Shah, S. J., Anand, I. S., Fang, J. C., Zile, M. R., Pitt, B., Solomon, S. D., & Shah, A. M. (2016). Prognostic relevance of left atrial dysfunction in heart failure with preserved ejection fraction. Circulation: Heart Failure, 9(4), e002763.PubMed
17.
go back to reference Timoteo, A. T., Moura Branco, L., Filipe, F., Galrinho, A., Rio, P., Portugal, G., Oliveira, S., & Ferreira, R. C. (2019). Cardiotoxicity in breast cancer treatment: What about left ventricular diastolic function and left atrial function? Echocardiography, 36(10), 1806–1813.CrossRefPubMed Timoteo, A. T., Moura Branco, L., Filipe, F., Galrinho, A., Rio, P., Portugal, G., Oliveira, S., & Ferreira, R. C. (2019). Cardiotoxicity in breast cancer treatment: What about left ventricular diastolic function and left atrial function? Echocardiography, 36(10), 1806–1813.CrossRefPubMed
18.
go back to reference Sueta, D., Usuku, H., Kinoshita, Y., & Tsujita, K. (2020). Left atrial function assessed by speckle tracking echocardiography in anthracycline-induced cardiotoxicity: A case report. European Heart Journal: Case Reports, 4(6), 1–5.PubMedPubMedCentral Sueta, D., Usuku, H., Kinoshita, Y., & Tsujita, K. (2020). Left atrial function assessed by speckle tracking echocardiography in anthracycline-induced cardiotoxicity: A case report. European Heart Journal: Case Reports, 4(6), 1–5.PubMedPubMedCentral
19.
go back to reference Beavers, C. J., Rodgers, J. E., Bagnola, A. J., Beckie, T. M., Campia, U., Di Palo, K. E., Okwuosa, T. M., Przespolewski, E. R., & Dent, S. (2022). On behalf of the American heart association clinical pharmacology committee and cardio-oncology committee of the council on clinical cardiology and council on genomic and precision medicine; and the council on peripheral vascular disease. Cardio-oncology drug interactions: a scientific statement from the American heart association. Circulation, 145, e811–e838.PubMed Beavers, C. J., Rodgers, J. E., Bagnola, A. J., Beckie, T. M., Campia, U., Di Palo, K. E., Okwuosa, T. M., Przespolewski, E. R., & Dent, S. (2022). On behalf of the American heart association clinical pharmacology committee and cardio-oncology committee of the council on clinical cardiology and council on genomic and precision medicine; and the council on peripheral vascular disease. Cardio-oncology drug interactions: a scientific statement from the American heart association. Circulation, 145, e811–e838.PubMed
20.
go back to reference Plana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., Ganame, J., Sebag, I. A., Agler, D. A., Badano, L. P., & Banchs, J. (2014). Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American society of echocardiography and the european association of cardiovascular imaging. European Heart Journal-Cardiovascular Imaging, 15(10), 1063–1093.CrossRefPubMedPubMedCentral Plana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., Ganame, J., Sebag, I. A., Agler, D. A., Badano, L. P., & Banchs, J. (2014). Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American society of echocardiography and the european association of cardiovascular imaging. European Heart Journal-Cardiovascular Imaging, 15(10), 1063–1093.CrossRefPubMedPubMedCentral
21.
go back to reference Douglas, P. S., Carabello, B. A., Lang, R. M., Lopez, L., Pellikka, P. A., Picard, M. H., Thomas, J. D., Varghese, P., Wang, T. Y., Weissman, N. J., & Wilgus, R. (2019). 2019 ACC/AHA/ASE key data elements and definitions for transthoracic echocardiography: A report of the American college of cardiology/American heart association task force on clinical data standards (writing committee to develop clinical data standards for transthoracic echocardiography) and the American Society of Echocardiography. Circulation: Cardiovascular Imaging, 12(7), e000027.PubMed Douglas, P. S., Carabello, B. A., Lang, R. M., Lopez, L., Pellikka, P. A., Picard, M. H., Thomas, J. D., Varghese, P., Wang, T. Y., Weissman, N. J., & Wilgus, R. (2019). 2019 ACC/AHA/ASE key data elements and definitions for transthoracic echocardiography: A report of the American college of cardiology/American heart association task force on clinical data standards (writing committee to develop clinical data standards for transthoracic echocardiography) and the American Society of Echocardiography. Circulation: Cardiovascular Imaging, 12(7), e000027.PubMed
22.
go back to reference Negishi, K., Negishi, T., Kurosawa, K., Hristova, K., Popescu, B. A., Vinereanu, D., Yuda, S., & Marwick, T. H. (2015). Practical guidance in echocardiographic assessment of global longitudinal strain. JACC: Cardiovascular Imaging, 8(4), 489–492.PubMed Negishi, K., Negishi, T., Kurosawa, K., Hristova, K., Popescu, B. A., Vinereanu, D., Yuda, S., & Marwick, T. H. (2015). Practical guidance in echocardiographic assessment of global longitudinal strain. JACC: Cardiovascular Imaging, 8(4), 489–492.PubMed
23.
go back to reference Badano, L. P., Kolias, T. J., Muraru, D., Abraham, T. P., Aurigemma, G., Edvardsen, T., D’Hooge, J., Donal, E., Fraser, A. G., Marwick, T., & Mertens, L. (2018). Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: A consensus document of the EACVI/ASE/industry task force to standardize deformation imaging. European Heart Journal-Cardiovascular Imaging, 19(6), 591–600.CrossRefPubMed Badano, L. P., Kolias, T. J., Muraru, D., Abraham, T. P., Aurigemma, G., Edvardsen, T., D’Hooge, J., Donal, E., Fraser, A. G., Marwick, T., & Mertens, L. (2018). Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: A consensus document of the EACVI/ASE/industry task force to standardize deformation imaging. European Heart Journal-Cardiovascular Imaging, 19(6), 591–600.CrossRefPubMed
24.
go back to reference Haji, K., Wong, C., Wright, L., Ramkumar, S., & Marwick, T. H. (2019). Left atrial strain performance and its application in clinical practice. JACC: Cardiovascular Imaging, 12(6), 1093–1101.PubMed Haji, K., Wong, C., Wright, L., Ramkumar, S., & Marwick, T. H. (2019). Left atrial strain performance and its application in clinical practice. JACC: Cardiovascular Imaging, 12(6), 1093–1101.PubMed
25.
go back to reference Nemeth, B. T., Varga, Z. V., Wu, W. J., & Pacher, P. (2017). Trastuzumab cardiotoxicity: From clinical trials to experimental studies. British Journal of Pharmacology, 174(21), 3727–3748.CrossRefPubMed Nemeth, B. T., Varga, Z. V., Wu, W. J., & Pacher, P. (2017). Trastuzumab cardiotoxicity: From clinical trials to experimental studies. British Journal of Pharmacology, 174(21), 3727–3748.CrossRefPubMed
26.
go back to reference Oikonomou, E. K., Kokkinidis, D. G., Kampaktsis, P. N., Amir, E. A., Marwick, T. H., Gupta, D., & Thavendiranathan, P. (2019). Assessment of prognostic value of left ventricular global longitudinal strain for early prediction of chemotherapy-induced cardiotoxicity: A systematic review and meta-analysis. JAMA cardiology, 4(10), 1007–1018.CrossRefPubMedPubMedCentral Oikonomou, E. K., Kokkinidis, D. G., Kampaktsis, P. N., Amir, E. A., Marwick, T. H., Gupta, D., & Thavendiranathan, P. (2019). Assessment of prognostic value of left ventricular global longitudinal strain for early prediction of chemotherapy-induced cardiotoxicity: A systematic review and meta-analysis. JAMA cardiology, 4(10), 1007–1018.CrossRefPubMedPubMedCentral
27.
go back to reference Dolci, G., Bergamini, C., Fiorio, E., & Ribichini, F. (2018). Irreversible left atrium dilatation preceding left ventricular dysfunction during trastuzumab therapy. Minerva Cardioangiologica, 66(2), 223–224.PubMed Dolci, G., Bergamini, C., Fiorio, E., & Ribichini, F. (2018). Irreversible left atrium dilatation preceding left ventricular dysfunction during trastuzumab therapy. Minerva Cardioangiologica, 66(2), 223–224.PubMed
28.
go back to reference Tadic, M., Genger, M., Cuspidi, C., Belyavskiy, E., Frydas, A., Dordevic, A., Morris, D. A., Völkl, J., Parwani, A. S., Pieske, B., & Haßfeld, S. (2019). Phasic left atrial function in cancer patients before initiation of anti-cancer therapy. Journal of Clinical Medicine, 8(4), 421.CrossRefPubMedPubMedCentral Tadic, M., Genger, M., Cuspidi, C., Belyavskiy, E., Frydas, A., Dordevic, A., Morris, D. A., Völkl, J., Parwani, A. S., Pieske, B., & Haßfeld, S. (2019). Phasic left atrial function in cancer patients before initiation of anti-cancer therapy. Journal of Clinical Medicine, 8(4), 421.CrossRefPubMedPubMedCentral
29.
go back to reference Park, H., Kim, K. H., Kim, H. Y., Cho, J. Y., Yoon, H. J., Hong, Y. J., Park, H. W., Kim, J. H., Ahn, Y., Jeong, M. H., & Cho, J. G. (2020). Left atrial longitudinal strain as a predictor of cancer therapeutics-related cardiac dysfunction in patients with breast cancer. Cardiovascular Ultrasound, 18, 1–8.CrossRef Park, H., Kim, K. H., Kim, H. Y., Cho, J. Y., Yoon, H. J., Hong, Y. J., Park, H. W., Kim, J. H., Ahn, Y., Jeong, M. H., & Cho, J. G. (2020). Left atrial longitudinal strain as a predictor of cancer therapeutics-related cardiac dysfunction in patients with breast cancer. Cardiovascular Ultrasound, 18, 1–8.CrossRef
30.
go back to reference Laufer-Perl, M., Arias, O., Dorfman, S. S., Baruch, G., Rothschild, E., Beer, G., Hasson, S. P., Arbel, Y., Rozenbaum, Z., Topilsky, Y., & Kapusta, L. (2021). Left atrial strain changes in patients with breast cancer during anthracycline therapy. International Journal of Cardiology, 330, 238–244.CrossRefPubMed Laufer-Perl, M., Arias, O., Dorfman, S. S., Baruch, G., Rothschild, E., Beer, G., Hasson, S. P., Arbel, Y., Rozenbaum, Z., Topilsky, Y., & Kapusta, L. (2021). Left atrial strain changes in patients with breast cancer during anthracycline therapy. International Journal of Cardiology, 330, 238–244.CrossRefPubMed
31.
go back to reference Di Lisi, D., Moreo, A., Casavecchia, G., Cadeddu Dessalvi, C., Bergamini, C., Zito, C., Madaudo, C., Madonna, R., Cameli, M., & Novo, G. (2023). Atrial strain assessment for the early detection of cancer therapy-related cardiac dysfunction in breast cancer women (the strano study: Atrial strain in cardio-oncology). Journal of Clinical Medicine, 16(12), 7127.CrossRef Di Lisi, D., Moreo, A., Casavecchia, G., Cadeddu Dessalvi, C., Bergamini, C., Zito, C., Madaudo, C., Madonna, R., Cameli, M., & Novo, G. (2023). Atrial strain assessment for the early detection of cancer therapy-related cardiac dysfunction in breast cancer women (the strano study: Atrial strain in cardio-oncology). Journal of Clinical Medicine, 16(12), 7127.CrossRef
32.
go back to reference Bergamini, C., Torelli, F., Ghiselli, L., Rossi, A., Trevisani, L., Vinco, G., Truong, S., Benfari, G., Golia, G., Molino, A., & Vassanelli, C. (2016). Left ventricular end-diastolic volume as early indicator of trastuzumab-related cardiotoxicity in HER2+ breast cancer patients: Results from a single-center retrospective study. Minerva Cardioangiologica, 65(3), 278–287.PubMed Bergamini, C., Torelli, F., Ghiselli, L., Rossi, A., Trevisani, L., Vinco, G., Truong, S., Benfari, G., Golia, G., Molino, A., & Vassanelli, C. (2016). Left ventricular end-diastolic volume as early indicator of trastuzumab-related cardiotoxicity in HER2+ breast cancer patients: Results from a single-center retrospective study. Minerva Cardioangiologica, 65(3), 278–287.PubMed
33.
go back to reference Bowles, E. J. A., Wellman, R., Feigelson, H. S., Onitilo, A. A., Freedman, A. N., Delate, T., Allen, L. A., Nekhlyudov, L., Goddard, K. A., Davis, R. L., & Habel, L. A. (2012). Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: A retrospective cohort study. Journal of the National Cancer Institute, 104(17), 1293–1305.CrossRefPubMedPubMedCentral Bowles, E. J. A., Wellman, R., Feigelson, H. S., Onitilo, A. A., Freedman, A. N., Delate, T., Allen, L. A., Nekhlyudov, L., Goddard, K. A., Davis, R. L., & Habel, L. A. (2012). Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: A retrospective cohort study. Journal of the National Cancer Institute, 104(17), 1293–1305.CrossRefPubMedPubMedCentral
34.
go back to reference Henry, M. L., Niu, J., Zhang, N., Giordano, S. H., & Chavez-MacGregor, M. (2018). Cardiotoxicity and cardiac monitoring among chemotherapy-treated breast cancer patients. JACC: Cardiovascular Imaging, 11(8), 1084–1093.PubMed Henry, M. L., Niu, J., Zhang, N., Giordano, S. H., & Chavez-MacGregor, M. (2018). Cardiotoxicity and cardiac monitoring among chemotherapy-treated breast cancer patients. JACC: Cardiovascular Imaging, 11(8), 1084–1093.PubMed
35.
go back to reference Russo, G., Cioffi, G., Gori, S., Tuccia, F., Boccardi, L., Khoury, G., Lestuzzi, C., Maurea, N., Oliva, S., Faggiano, P., & Tarantini, L. (2014). Role of hypertension on new onset congestive heart failure in patients receiving trastuzumab therapy for breast cancer. Journal of Cardiovascular Medicine, 15(2), 141–146.CrossRefPubMed Russo, G., Cioffi, G., Gori, S., Tuccia, F., Boccardi, L., Khoury, G., Lestuzzi, C., Maurea, N., Oliva, S., Faggiano, P., & Tarantini, L. (2014). Role of hypertension on new onset congestive heart failure in patients receiving trastuzumab therapy for breast cancer. Journal of Cardiovascular Medicine, 15(2), 141–146.CrossRefPubMed
Metadata
Title
Role of Early Left Atrial Functional Decline in Predicting Cardiotoxicity in HER2 Positive Breast Cancer Patients Treated With Trastuzumab
Authors
Corinna Bergamini
Lorenzo Niro
Paolo Springhetti
Luisa Ferri
Laura Trento
Ilaria Minnucci
Caterina Maffeis
Elvin Tafciu
Andrea Rossi
Elena Fiorio
Giovanni Benfari
Flavio Ribichini
Publication date
02-05-2024
Publisher
Springer US
Published in
Cardiovascular Toxicology / Issue 6/2024
Print ISSN: 1530-7905
Electronic ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-024-09861-6

Other articles of this Issue 6/2024

Cardiovascular Toxicology 6/2024 Go to the issue
Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Medication non-adherence is a major barrier to effective healthcare delivery; half of all patients do not follow their doctor’s recommendations or treatment plan.

Our experts explain the fundamentals with a practical discussion of how to manage non-adherence in two common scenarios: hypertension and asthma control.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine